News | March 19, 2026
Strides acquires generic brands from Sandoz to boost Africa business
The initial consideration for the transaction is US$ 12 million
The initial consideration for the transaction is US$ 12 million
The partnership will focus on advancing fault-tolerant quantum algorithms and developing clinically relevant quantum applications
Cadila Pharmaceuticals’ journey has been marked by several milestones, including the development of indigenous formulations, expansion into global markets, and the creation of robust manufacturing and R&D capabilities
Industry leaders highlighted the pharmaceutical sector’s role in advancing research, innovation, early screening, and multi-stakeholder collaboration
Germany will be the first launch market
The first of four planned modules at the new plant is expected to come online by summer 2026
New partnership combines Shilpa Biologicals’ development and manufacturing capabilities with SteinCares’ regional commercialization platform
The program provides pharmaceutical manufacturers with auditable, primary emissions data and verified proof of a 30% CO? reduction across DFE Pharma’s lactose portfolio
The new service delivers end-to-end support, managing every stage of an epigenomics project
Subscribe To Our Newsletter & Stay Updated
